Bank of America’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bank of America’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,600	Closed	-$640K	–	7456
2018 Q1	$640K	Buy	+19,600	New	+$860K	﹤0.01%	4669
2017 Q3	–	Sell	-110,000	Closed	-$6.18M	–	7391
2017 Q2	$6.18M	Buy	110,000 +17,500	+19%	+$701K	﹤0.01%	2837
2017 Q1	$3.63M	Buy	+92,500	New	+$2.95M	﹤0.01%	3333

Bank of America's PTLA Position: Q3 2020 in Review

Bank of America sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 554,943 shares — an estimated $9.98M sold.

Bank of America first reported a position in PTLA in Q2 2013 and held it in 29 quarters. The position peaked at $20.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Bank of America reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Bank of America sold 554,943 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.98M.
Bank of America first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
Bank of America's Portola Pharmaceuticals, Inc. position peaked at $20.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.